Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Embracing Future Holdings Limited
No Price
Closing Price XSES 29.04.2026:
0,05 SGD
29.04.2026 06:41
Current Prices from Embracing Future Holdings Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
SGX
8YY.SI
SGD
29.04.2026 06:41
0,05 SGD
0,00 SGD
Share Float & Liquidity
Free Float51,74 %
Shares Float896,97 M
Shares Outstanding1,73 B
Company Profile for Embracing Future Holdings Limited Share
Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also provides laboratory services. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. The company was incorporated in 2009 and is based in Singapore.
